Intrinsiqq
Electra Therapeutics, Inc. logo

Electra Therapeutics, Inc. Financials

ETRA

Compare

SourceFinancial statements computed from the 10-Q filed 12 Nov 2026, covering the period ending 30 Sept 2026, as reported to the SEC. Data last refreshed 13 Nov 2026. How this is calculated.

Fiscal year ends Dec.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with ETRA

CompareIntrinsic value
DYAIDyadic International Inc.
$0.29-6.45%25
VIVSVivoSim Labs, Inc.
$0.26-10.34%10
BCDABioCardia, Inc.
$0.79+2.60%26
PLURPluri Inc.
$0.94-3.09%30
PROKProKidney Corp
$1.04-1.89%10
CADLCandel Therapeutics Inc.
$5.04-1.75%10
PRMEPrime Medicine Inc.
$3.55-7.55%0
TECHBio-Techne Corporation
$72.67-0.04%41

Spot a number that looks wrong? Check it in ETRA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing ETRA

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.